Guest Open Access | Free Content | About | Sign in | New Users: Sign up | Mark List  

 

Current Drug Safety

Volume 3 Issue 2
ISSN: 1574-8863

 

   All Titles

  Managing Safety Signals in Large Endpoint Trials
  pp.86-90 (5) Author: Demissie Alemayehu
 
 
      Abstract

We consider the management of safety signals that arise in the context of endpoint trials. Such trials have design features which permit the detection of signals that otherwise may be missed in more traditional settings. However, the approaches that are typically employed to address them are less than satisfactory in terms of both the analytical techniques and the communication of the findings. In this paper, alternative approaches are evaluated, and recommendations are given for a comprehensive strategy that involves appropriate use of study data as well as information external to the study. It is emphasized that formulation and implementation of an effective communication plan that enables informed decision making should be an integral component of the strategy.

 
  Keywords: Endpoint trials, competing risks, safety evaluation, cardiovascular risk
  Affiliation: Global Medical Statistics Department, Pfizer Inc., 235, East 42nd Street/685-12, New York, NY 10017, USA.
 
  Key: New Content Free Content Open Access Subscribed Content

 
Bentham Science Publishers
www.bentham.org

  Copyright © 1994 - 2010   Bentham Science Publishers Ltd.